{"id":391462,"date":"2014-12-29T00:00:00","date_gmt":"2014-12-29T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/pcorid0114-biopharma-hepatitis-c-virus-pharmacor-g7-2014\/"},"modified":"2026-04-14T10:29:17","modified_gmt":"2026-04-14T10:29:17","slug":"pcorid0114-biopharma-hepatitis-c-virus-pharmacor-g7-2014","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/pcorid0114-biopharma-hepatitis-c-virus-pharmacor-g7-2014\/","title":{"rendered":"Hepatitis C Virus | Pharmacor | G7 | 2014"},"content":{"rendered":"<p><em>Last Updated 29 December 2014 <\/em><br \/>\nHepatitis C virus (HCV) is the leading cause of end-stage liver disease and hepatocellular carcinoma. Treatment of it represents a large untapped market owing to high prevalence, a large pool of previously diagnosed, untreated, \u201cwarehoused\u201d patients, and a substantial population of nonresponders who have not achieved sustained virologic response (SVR). The recent and imminent launches of multiple, very tolerable and effective, all-oral, interferon-free regimens will more than triple the number of drug-treated HCV patients in the major pharmaceutical markets under study and cause sales of HCV therapies to soar to nearly $30 billion during the forecast period.<\/p>\n","protected":false},"template":"","class_list":["post-391462","report","type-report","status-publish","hentry","report-gateway-biopharma","biopharma-therapy-areas-hepatitis-c-virus","biopharma-geography-us","biopharma-date-574"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/391462","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":1,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/391462\/revisions"}],"predecessor-version":[{"id":394585,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/391462\/revisions\/394585"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=391462"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}